Plasma Soluble ST2 Levels Correlate With Disease Severity and Predict Clinical Worsening in Patients With Pulmonary Arterial Hypertension

Pim-1: A New Biomarker in Pulmonary Arterial Hypertension

(2014) Sébastien Renard et al.   Pulmonary Circulation

Serum levels of the soluble IL-1 receptor family member ST2 and right ventricular dysfunction

(2013) Lucia Agoston-Coldea et al.   Biomarkers in Medicine

Soluble ST2 and N-terminal pro-Brain Natriuretic Peptide Combination

(2013) Ayako Chida et al.   CIRCULATION JOURNAL

Adiponectin Levels Are Elevated in Patients With Pulmonary Arterial Hypertension

(2013) Mário Santos et al.   CLINICAL CARDIOLOGY

Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension

(2013) Guido Carlomagno et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

(2013) Tomás Pulido et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of Exercise-Induced Pulmonary Arterial Hypertension by Cardiopulmonary Exercise Testing

(2012) Martin Schwaiblmair et al.   CLINICAL CARDIOLOGY

The Presage®ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2

(2012) Thomas Mueller et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Heart Rate Recovery Predicts Clinical Worsening in Patients with Pulmonary Arterial Hypertension

(2011) Omar A. Minai et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Role of ST2 in Non-ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial

(2011) P. Kohli et al.   CLINICAL CHEMISTRY

Association of ST2 levels with cardiac structure and function and mortality in outpatients

(2010) Lori B. Daniels et al.   AMERICAN HEART JOURNAL

High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure

(2010) Bonnie Ky et al.   Circulation-Heart Failure

A Retrospective Review to Evaluate the Safety of Right Heart Catheterization via the Internal Jugular Vein in the Assessment of Pulmonary Hypertension

(2010) Harpreet Ranu et al.   CLINICAL CARDIOLOGY

Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy

(2010) M. D'Alto et al.   HEART

Serum Soluble ST2

(2010) Robin A.P. Weir et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

S154 Is there a role for IL-33 in the pathogenesis of pulmonary arterial hypertension?

(2010) D. Shao et al.   THORAX

S155 The role of ST2 in a model of pulmonary hypertension

(2010) A. Mahmood et al.   THORAX

The Right Ventricle Under Pressure

(2009) Harm J. Bogaard et al.   CHEST

Serum Levels of the Interleukin-1 Receptor Family Member ST2, Cardiac Structure and Function, and Long-Term Mortality in Patients With Acute Dyspnea

(2009) Ravi V. Shah et al.   Circulation-Heart Failure

Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma — The Presage™ ST2 assay

(2009) Benjamin Dieplinger et al.   CLINICA CHIMICA ACTA

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Nonmyocardial Production of ST2 Protein in Human Hypertrophy and Failure Is Related to Diastolic Load

(2008) Jozef Bartunek et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure

(2008) Shafiq U. Rehman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The IL-33/ST2 pathway: therapeutic target and novel biomarker

(2008) Rahul Kakkar et al.   NATURE REVIEWS DRUG DISCOVERY